Therefore, further understanding the effect of NLRP3 inflammasome activation in neutrophil may provide insight into pathology and identify new therapeutic targets for the clinical treatment of neutrophilic inflammatory reactions in bronchiectasis. The gene discussed is NLRP3; the disease is bronchiectasis.